Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05838950 · ClinicalTrials.gov registry record · NA

HIIT Effects on Cardiometabolic Health

A NA study of Obesity and Cardiovascular Diseases, sponsored by Syracuse University.

Recruiting
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT05838950: Recruiting NA study of Obesity and Cardiovascular Diseases, sponsored by Syracuse University.

NCT05838950 is a NA study of Obesity and Cardiovascular Diseases that is actively recruiting participants, run by Syracuse University. The registered enrollment target is 60 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05838950, a NA study of Obesity and Cardiovascular Diseases, is actively recruiting participants, sponsored by Syracuse University.

RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

The primary aim of this randomized clinical trial is to compare the effects of three different HIIT protocols and a control group on cardiometabolic health in young adults with obesity. Participants will be randomly assigned to one of the following three groups, with each having varying work-to-rest ratios: 1) HIIT-A, 2) HIIT-B, 3) HIIT-C, and 4) control group. HIIT-A, HIIT-B, and HIIT-C groups will participate in six sessions of a running based HIIT program over a 2-week training period. Pre-clinical markers of cardiovascular disease, blood lipids and fasting glucose will be measured at the following three time points: baseline, post-intervention, and 2 weeks after the training cessation (i.e., measure for detraining effect). All measurements will be performed three days before the training program and three days after the intervention to avoid the effect of the last training session. Afterwards, the detraining test will be measured 2 weeks post intervention.

Primary Outcome

Height (cm)

Interventions

  • OTHER high-intensity interval training intervention

Study Locations (1)

New York

  • Women's Building - Syracuse

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2023-09-29
Est. Completion 2025-12-10
Phase NA
Syracuse University

31 total trials

What NCT05838950 shows while recruiting

NCT05838950 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (93% lower).

The record links to 4 conditions, with Obesity appearing as the primary indexed condition, and to 1 intervention - of which high-intensity interval training intervention is the first listed.

NCT05838950 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT05838950 about?

NCT05838950 is a clinical study titled "HIIT Effects on Cardiometabolic Health". The primary aim of this randomized clinical trial is to compare the effects of three different HIIT protocols and a control group on cardiometabolic health in young adults with obesity. Participants will be randomly assigned to one of the following three groups, with each having varying work-to-rest...

What is the current status of trial NCT05838950?

This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2023-09-29. Estimated completion is 2025-12-10.

What conditions does trial NCT05838950 study?

This clinical trial studies the following conditions: Obesity, Cardiovascular Diseases, Metabolic Disease, High Intensity Interval Training.

What interventions are being tested in trial NCT05838950?

The interventions under investigation include: high-intensity interval training intervention (OTHER).

Who is sponsoring clinical trial NCT05838950?

This trial is sponsored by Syracuse University, which has 31 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05838950 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05838950's enrollment target sits among peer trials

60 642nd of 1053 higher than 374 of 1,053 other Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01734122 · 60 participants

    Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05838950, the US trial registry maintained by the National Library of Medicine. NCT05838950 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.